Annual rate of newly treated atrial fibrillation by age and gender in France, 2010–2016

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

(2018) Jan Steffel et al.   EUROPEAN HEART JOURNAL

Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases

(2018) Laetitia Huiart et al.   BMJ Open

Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry

(2017) Giuseppe Boriani et al.   EUROPACE

Female gender as a risk factor for stroke associated with atrial fibrillation

(2017) A. John Camm et al.   EUROPEAN HEART JOURNAL

Identifying atrial fibrillation in outpatients initiating oral anticoagulants based on medico-administrative data: results from the French national healthcare databases

(2017) Cécile Billionnet et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology

(2017) Julien Bezin et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Value of a national administrative database to guide public decisions: From the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France

(2017) P. Tuppin et al.   REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE

Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD

(2017) Laure Lacoin et al.   BMJ Open

Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis

(2017) Vidar Ruddox et al.   European Journal of Preventive Cardiology

Sex Differences in the Use of Oral Anticoagulants for Atrial Fibrillation: A Report From the National Cardiovascular Data Registry (NCDR ® ) PINNACLE Registry

(2017) Lauren E. Thompson et al.   Journal of the American Heart Association

Incidence, type of atrial fibrillation and risk factors for stroke: a population-based cohort study

(2017) Cecilia Johansson et al.   Clinical Epidemiology

Trends in the prevalence and management of pre-stroke atrial fibrillation, the South London Stroke Register, 1995-2014

(2017) Vageesh Jain et al.   PLoS One

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

(2016) A John Camm et al.   HEART

Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke

(2016) Jonathan C. Hsu et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France

(2015) Francois-Emery Cotté et al.   EUROPACE

Recent time trends in incidence, outcome and premorbid treatment of atrial fibrillation-related stroke and other embolic vascular events: a population-based study

(2015) Gabriel S C Yiin et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study

(2015) Renate B Schnabel et al.   LANCET

Socioeconomic Inequalities in the Prescription of Oral Anticoagulants in Stroke Patients With Atrial Fibrillation

(2015) Maria Sjölander et al.   STROKE

Sex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) Database

(2014) Pierre Sabouret et al.   Clinical Research in Cardiology

Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study

(2014) Valeria Raparelli et al.   Internal and Emergency Medicine

Worldwide Epidemiology of Atrial Fibrillation

(2013) Sumeet S. Chugh et al.   CIRCULATION

Neighbourhood deprivation and hospitalization for atrial fibrillation in Sweden

(2013) B. Zoller et al.   EUROPACE

Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007

(2012) Jonathan P. Piccini et al.  

Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients

(2012) T. Wilke et al.   EUROPACE

Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of French hospitalization data

(2011) Agnès Charlemagne et al.   Archives of Cardiovascular Diseases

Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections

(2011) Hrafnhildur Stefansdottir et al.   EUROPACE

Ecological association between a deprivation index and mortality in France over the period 1997 – 2001: variations with spatial scale, degree of urbanicity, age, gender and cause of death

(2009) Grégoire Rey et al.   BMC PUBLIC HEALTH

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006

(2009) Y. Bejot et al.   NEUROLOGY